Algorithm predicts females have higher risk for kidney damage after aneurysm repair

The risk was higher regardless of a female patient’s kidney function or aneurysm size

1:20 PM

Author | Noah Fromson

kidneys blue yellow
Justine Ross, Jacob Dwyer, Michigan Medicine

When receiving treatment for abdominal aortic aneurysm, female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study finds.

Researchers from Michigan Medicine designed an algorithm that can be used prior to endovascular abdominal aortic aneurysm repair to identify risk for kidney damage. They tested the algorithm using data from over 7,000 patients through the Blue Cross Blue Shield of Michigan Cardiovascular Consortium database.

The risk prediction algorithm, according to findings published in Annals of Vascular Surgery, demonstrated that women receiving endovascular aneurysm repair had 1.4 times higher odds of developing acute kidney injury after aneurysm repair.

“While we have seen higher risk of acute kidney injury in female patients who have undergone coronary stenting or renal stenting, this is the first time we are seeing a higher risk after endovascular abdominal aortic aneurysm repair,” said senior author Peter Henke, M.D., FACS, FAHA, vascular surgeon and director of the University of Michigan Health Frankel Cardiovascular Center.

Patients with reduced glomerular filtration rate, an indicator of kidney disease, had 4.7 times higher odds of developing acute kidney injury after aneurysm repair. Those with larger aneurysms were also at increased risk. These findings are less surprising than the higher odds of kidney injury in women, investigators say, given patients’ decreased renal function at baseline and the possible prolonged procedures and intra-operative contrast loads that come with larger aneurysms.

Abdominal aortic aneurysm is the most common form of aneurysm, affecting around 5% of the global population. The Michigan Medicine research team hopes to implement the algorithm in clinical practice to provide at-risk patients with optimization before an operation.

“Kidney injury after surgery can be benign, but for some patients it leads to permanent renal failure and, in some instances, dialysis,” said Drew Braet, M.D., first author and vascular surgery resident at U-M Health. “This algorithm shows that we can use easily attainable factors prior to surgery that may help identify patients at risk of complications during their surgery and, thus, ensure we are optimizing these patients accordingly. If we can protect patients and decrease their risk of permanent renal failure, then we have truly provided them a benefit.”

Additional authors include Nathan J. Graham, Jeremy Albright, Ph.D., and Nicholas H. Osborne, M.D., all of Michigan Medicine

Support for BMC2 is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. Although Blue Cross Blue Shield of Michigan and BMC2 work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.

Paper cited: “A novel pre-operative risk assessment tool to identify patients at risk of contrast associated acute kidney injury after endovascular abdominal aortic aneurysm repair,” Annals of Vascular Surgery. DOI: 10.1016/j.avsg.2023.02.017

 


More Articles About:

Aortic Aneurysm Aortic Disease cardiovascular Cardiovascular: Treatment & Surgery Vascular Surgery Cardiovascular: Diagnostics & Procedures Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related

Man leaning against tree by road grabbing his chest
Health Lab

Death rate for torn aorta drops, still 5 times more deadly without surgery

The study finds nearly 96% of patients deemed eligible for surgery survive in the first 48 hours.

Featured News & Stories

A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.
Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.
Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.
Patient lying on hospital bed with blue shirt emblazoned with "heart of gold" surrounded by four medical team members.
Health Lab

Heart of Gold: Rare metal allergy leads to a unique heart device

Patient diagnosed with heart failure finds a gold plated implant is solution to her cardiovascular issues.
Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.